News

In a recently published study in Nature Metabolism, scientists have made important advances in understanding the biological influences on the human plasma proteome. The study was conducted by BIH Professor Claudia Langenberg and her team and analyzed data from 8,350 predominantly healthy, middle-aged men and women from the United Kingdom.

The Advanced Therapies in Orthopaedics Foundation (ATiO) has recently announced an exciting new partnership with the Osteoarthritis Research Society International (OARSI). This collaboration brings together leading global experts from all professions in orthopaedics and osteoarthritis to foster innovation in advanced therapies for joint diseases.

The Berlin startup Lucid Genomics, a spin-off of the Max Planck Institute for Molecular Genetics and Charité - Universitätsmedizin Berlin, uses AI-based tools to decode previously undiscovered parts of human DNA. Founders Uirá Souto Melo and Hossein Moeinzadeh have now received 1.3 million euros in pre-seed funding to further develop their…

Researchers from the University of Lausanne and the Berlin Institute of Health at Charité (BIH) present a new sorting method to optimize the effect of bacterial communities for efficient degradation of environmental pollutants.

Prof. Christian Gaebler, an HIV researcher at Charité – Universitätsmedizin Berlin, has a goal: to develop treatments that cure HIV infection in patients or prompt the immune system to keep the virus in check in the long term, even without medications.

A new collaborative study by researchers from the Berlin Institute of Health at Charité (BIH), Queen Mary University of London, University College London, University of Cambridge and the pharmaceutical company GlaxoSmithKline (GSK) shows that proteins measured in a single drop of blood can predict risk for a variety of diseases.

Immunotherapies harness the body’s immune system to fight cancer by influencing the interaction between immune cells and cancer cells. Such treatments have proved successful in combating certain types of cancers like leukemia, but they remain ineffective in some patients and cause resistance. A research group led by Prof. Simon Haas, which is part…

At a festive award ceremony on 26 June 2024 at Berliner Sparkasse in Wannsee, UniWearables UG by Raphael Lang and Maximilian Blendinger was awarded 2nd place in the "Science & Startups" prize of Berliner Sparkasse. UniWearables, supported by Charité BIH Innovation (CBI), the joint technology transfer of Charité and Berlin Institute of Health (BIH),…